论文部分内容阅读
目的 评价新编制的“婴儿异常运动功能评定表”重测信度、内部一致信度和平行效度 ,为应用该评定表在婴儿期筛查脑瘫提供简便、可行的工具。方法 对 16例 6～ 9个月龄的脑瘫患儿间隔 1～ 2周评定“婴儿异常运动功能评定表”的重测信度 ,对 36例 1岁内脑瘫患儿检查 ,计算Kuder Richardson系数 (rKR2 0 ) ,评价内部一致性信度。对 16例 6～ 9个月的脑瘫患儿和 6 8例 6个月正常婴儿分别用“婴儿异常运动功能评定表”和Morgan等编制的“早期运动模式量表”进行评定 ,分析两者评分相关性和对脑瘫患儿的区分能力。结果 “婴儿异常运动功能评定表”重测一致率为 97.1% ,Kappa值为 0 92 ;运动里程碑和神经反射 (原始反射与姿势反应 )rKR2 0 分别为0 5 4和 0 6 9。与“早期运动模式量表”同时对脑瘫患儿评分的相关系数为 0 85 (tr=3.0 5 34,P =0 0 0 0 ) ,“婴儿异常运动功能评定表”和“早期运动模式量表”对脑瘫患儿的区分能力分别为 10 0 % (16 / 16 )和 87.5 % (14 / 16 )。结论 “婴儿异常运动功能评定表”信度满意 ,其平行效度不低于国外用于脑瘫早期筛查的量表。
OBJECTIVE To evaluate the retest reliability, internal consistency and parallel validity of the newly developed “Abnormal Motor Function Assessment Table”, and provide a convenient and feasible tool for screening cerebral palsy in infancy. Methods Sixty-six children aged 6-9 months with cerebral palsy were retested one week to two weeks to assess the test-retest reliability of abnormal motor function in infants. 36 children with cerebral palsy were examined and calculated Kuder Richardson coefficient rKR20) to evaluate the internal consistency reliability. Sixteen children with cerebral palsy aged 6 to 9 months and 68 normal infants aged 6 months were evaluated by “Abnormal Motor Function Assessment Table” and “Early Exercise Model Scale” by Morgan et al. Respectively. The scores of the two groups Relevance and ability to distinguish children with cerebral palsy. Results The consistency of retesting rate was 97.1% with a Kappa value of 0 92. The motor milestones and neurological reflexes (original reflexes and postural responses) rKR20 were 0 54 and 0 69, respectively. The correlation coefficient of scoring of children with cerebral palsy at the same time as the “Early Mode of Exercise Scale” was 0 85 (tr = 3.0534, P = 0.0000), “abnormal motor function evaluation table of infants” and "early exercise mode scale The ability to distinguish children with cerebral palsy was 100% (16/16) and 87.5% (14/16), respectively. Conclusion The evaluation table of abnormal motor function in infants is satisfactory, and its parallel validity is not lower than that of foreign countries used for early screening of cerebral palsy.